Titelia

Holdings of T. Rowe Price Institutional Mid-Cap Equity Growth Fund

T. Rowe Price Equity Funds, Inc. ·113 declared positions · as of Mar 31, 2026

Original filing · Net assets 2.8B $ · Ten largest lines: 20.6 % of the equity sleeve

Sector breakdown

  • Consumer discretionary 14.1 %
  • Technology 13.2 %
  • Health care 10.8 %
  • Industrials 10.3 %
  • Financials 4.3 %
  • Energy 3.9 %
  • Materials 2.8 %
  • Consumer staples 0.8 %
  • Communication 0.3 %
  • Unattributed 39.4 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 92.9 %
  • BM 2.0 %
  • GB 1.8 %
  • CA 0.8 %
  • JE 0.7 %
  • CH 0.7 %
  • NL 0.6 %
  • DE 0.4 %
  • KY 0.1 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US1042.4B $92.86 %
BM152.9M $2.01 %
GB147.4M $1.80 %
CA120.5M $0.78 %
JE119.3M $0.73 %
CH218.2M $0.69 %
NL116M $0.61 %
DE111.1M $0.42 %
KY12.7M $0.10 %

Positions

CompanySharesValueWeight
CG oncology Inc 90,5606.1M $0.22 %
CRISPR Therapeutics AG 128,3616.1M $0.22 %
Unity Software Inc 273,6316M $0.22 %
DraftKings Inc 266,4935.8M $0.21 %
Caris Life Sciences Inc 316,9265.7M $0.21 %
McGraw Hill Inc 402,7145.5M $0.20 %
Kymera Therapeutics Inc 64,5005.4M $0.20 %
Amphenol Corp 41,5005.2M $0.19 %
Aurora Innovation Inc 1,182,5324.9M $0.18 %
QuidelOrtho Corp 229,2003.8M $0.14 %
Revolution Medicines Inc 36,2003.5M $0.13 %
Nuvalent Inc 30,3663.1M $0.11 %
Bullish 76,8892.7M $0.10 %